Magnify

Magnify

AI-powered post-sales orchestration for growth

Overview

Magnify provides an AI-powered platform for post-sales orchestration and customer growth automation, designed for software companies. The platform helps Customer Success, Product, and Revenue teams manage the customer lifecycle at scale by turning data from systems like Salesforce, Gainsight, Pendo, and Snowflake into actionable insights. It uses AI and machine learning to identify what drives churn and expansion, then automatically delivers personalized engagement through emails and in-app messages. This no-code tool lets teams build and automate workflows that connect to existing enterprise systems, reducing manual work and letting teams focus on higher-value tasks. Magnify differentiates itself by creating a distinct category called “Customer Growth Automation,” emphasizing end-to-end lifecycle orchestration across multiple tools rather than building a single-point solution. Its goal is to increase product adoption, cut churn, and grow revenue for enterprise software customers.

About Magnify

Simplify's Rating
Why Magnify is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Company Size

11-50

Company Stage

Early VC

Total Funding

$12M

Headquarters

Seattle, Washington

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Manages over $5 billion in revenue for leading software companies, demonstrating strong enterprise adoption.
  • CGA Maturity Model framework positions Magnify as category leader in post-sales standardization and scaling.
  • Hired Mike Saffitz from Stripe as VP Engineering, strengthening product development and enterprise credibility.

What critics are saying

  • Gainsight's AI-native expansions leverage 10,000+ customer base to capture enterprise deals within 6-12 months.
  • OpenAI GPT-5 native plugins enable enterprises to build custom automations in-house, commoditizing Magnify's AI.
  • SaaS budget cuts force customers to consolidate tools and favor incumbents like Pendo over unproven startups.

What makes Magnify unique

  • First platform combining unified data integration, AI churn prediction, and automated multi-channel engagement.
  • Agentic AI Assistant proactively executes personalized motions across email, in-app, chat without manual intervention.
  • No-code interface enables Customer Success teams to deploy workflows without engineering resources or custom development.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$12M

Above

Industry Average

Funded Over

2 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Paid Vacation

Paid Holidays

401(k) Company Match

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Conference Attendance Budget

Professional Development Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Relocation Assistance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Education allowance

Gym Membership

Commuter Benefits

Meal Benefits

Legal Services

Employee Discounts

Employee Referral Bonus

Bereavement Leave

Vacation/Leave

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

3%

2 year growth

16%
Constellation Research
Oct 6th, 2025
HOT TAKE: Magnify.io Adds New Agentic Tools to Optimize Post-Sale Revenue Growth

To address this issue, Magnify, which bills itself as a customer growth optimization platform focused on post-sales optimization, has launched its new AI Assistant, an agent purpose-built to optimize key elements of post-sales revenue generation.

Magnify
Jun 23rd, 2025
Introducing the CGA Maturity Model: A New Blueprint for Scalable Post-Sales Growth

That's why Magnify is excited to launch the Customer Growth Automation (CGA) Maturity Model - a four-phase framework designed to help B2B companies baseline their current approach and identify what's needed to scale retention, renewals, and expansion more efficiently.

Securities and Exchange Commission
Feb 28th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

GeekWire
Sep 5th, 2023
Tech Moves: Adaptive Board Member Resigns; Tagboard Co-Founder Steps Down; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Conroy. (Adaptive Biotech Photo)— Seattle biotech company Adaptive Biotechnologies Corp. disclosed in a SEC filing that Kevin Conroy has stepped down from his position as board member.Adaptive announced Conroy’s appointment to its board in May 2019 as it was gearing up for its initial public offering. The company said his departure was voluntary and not a result of any disagreement with its operations, policies or practices.Conroy is the chairman and CEO of Exact Sciences, a publicly traded molecular diagnostics company that focuses on the detection of early-stage cancers. The Madison, Wis.-based firm reported more than $2 billion in revenue last year.The resignation comes after Adaptive board member Leslie Trigg voluntarily resigned in June.— David Meininger confirmed to GeekWire he stepped down from his role as CEO of Link Immunotherapeutics, a Seattle-based company that focuses on developing new immuno-oncology drugs

GeekWire
Sep 5th, 2023
Tech Moves: Adaptive Board Member Resigns; Tagboard Exec Steps Down; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Conroy. (Adaptive Biotech Photo)— Seattle biotech company Adaptive Biotechnologies Corp. disclosed in a SEC filing that Kevin Conroy has stepped down from his position as board member.Adaptive announced Conroy’s appointment to its board in May 2019 as it was gearing up for its initial public offering. The company said his departure was voluntary and not a result of any disagreement with its operations, policies or practices.Conroy is the chairman and CEO of Exact Sciences, a publicly traded molecular diagnostics company that focuses on the detection of early-stage cancers. The Madison, Wis.-based firm reported more than $2 billion in revenue last year.The resignation comes after Adaptive board member Leslie Trigg voluntarily resigned in June.— David Meininger confirmed to GeekWire he stepped down from his role as CEO of Link Immunotherapeutics, a Seattle-based company that focuses on developing new immuno-oncology drugs

Recently Posted Jobs

Sign up to get curated job recommendations

Magnify is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →